Cosmecca Korea Co. Ltd Net Assets

Latest as of June 2026: ₩334.61 Billion KRW ≈ $226.76 Million USD

Cosmecca Korea Co. Ltd net assets. Based on the latest financial reports, Cosmecca Korea Co. Ltd (241710) has net assets worth ₩334.61 Billion KRW (≈ $226.76 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩734.66 Billion ≈ $497.87 Million USD) and total liabilities (₩400.05 Billion ≈ $271.11 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Cosmecca Korea Co. Ltd growing its equity to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩334.61 Billion
% of Total Assets 45.55%
Annual Growth Rate 13.83%
5-Year Change 136.37%
10-Year Change N/A
Growth Volatility 19.07

Net Assets of Cosmecca Korea Co. Ltd (2016–2025)

Net assets of Cosmecca Korea Co. Ltd from 2016 to 2025. This chart illustrates how Cosmecca Korea Co. Ltd's net assets have evolved over time, based on quarterly financial data. See Cosmecca Korea Co. Ltd (241710) balance sheet quality index to measure how much of total assets are equity-financed.

Annual Net Assets for Cosmecca Korea Co. Ltd (2016–2025)

The table below shows the annual net assets of Cosmecca Korea Co. Ltd from 2016 to 2025. For live market cap and overall valuation, see 241710 market cap overview.

Year Net Assets Change
2025-12-31 ₩336.24 Billion
≈ $227.86 Million
+9.30%
2024-12-31 ₩307.64 Billion
≈ $208.48 Million
+27.03%
2023-12-31 ₩242.17 Billion
≈ $164.11 Million
+65.13%
2022-12-31 ₩146.65 Billion
≈ $99.39 Million
+3.10%
2021-12-31 ₩142.25 Billion
≈ $96.40 Million
+9.63%
2020-12-31 ₩129.76 Billion
≈ $87.94 Million
+1.60%
2019-12-31 ₩127.72 Billion
≈ $86.55 Million
+2.19%
2018-12-31 ₩124.97 Billion
≈ $84.69 Million
+10.14%
2017-12-31 ₩113.47 Billion
≈ $76.90 Million
+8.23%
2016-12-31 ₩104.84 Billion
≈ $71.05 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Cosmecca Korea Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 442.0% over the analyzed period, indicating profitable operations and earnings retention.

Cosmecca Korea Co. Ltd Net Assets Breakdown (December 2025)

Cosmecca Korea Co. Ltd net assets breakdown by equity component as of December 2025.

Component Amount Percentage
Retained Earnings ₩173.75 Billion 68.75%
Other Components ₩78.98 Billion 31.25%
Total Equity ₩252.72 Billion 100.00%

Cosmecca Korea Co. Ltd Competitors by Market Cap

The table below lists competitors of Cosmecca Korea Co. Ltd ranked by their market capitalization.

Company Market Cap
Weihai Honglin Electronic Co. Ltd. A
SHE:301439
$696.35 Million
Quantum Corporation
NASDAQ:QMCO
$696.37 Million
Formosa International Hotels Corp
TW:2707
$696.41 Million
Daoming Optics&Chemical Co Ltd
SHE:002632
$696.46 Million
Lithium Americas Corp
TO:LAC
$695.94 Million
Jiangsu Zhenjiang New Energy Equipment Co Ltd Class A
SHG:603507
$695.77 Million
Doosan Pref Shs
KO:000155
$695.46 Million
Allied Supreme Corp
TW:4770
$695.43 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Cosmecca Korea Co. Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 218,410,742,830 to 252,723,282,040, a change of 34,312,539,210 (15.7%).
  • Net income of 45,439,905,660 contributed positively to equity growth.
  • Dividend payments of 2,312,124,750 reduced retained earnings.
  • Other factors decreased equity by 8,815,241,700.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income ₩45.44 Billion +17.98%
Dividends Paid ₩2.31 Billion -0.91%
Other Changes ₩-8.82 Billion -3.49%
Total Change ₩- 15.71%

Book Value vs Market Value Analysis

This analysis compares Cosmecca Korea Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 4.07x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 9.80x to 4.07x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 ₩9816.39 ₩96200.00 x
2017-12-31 ₩10624.39 ₩96200.00 x
2018-12-31 ₩11701.76 ₩96200.00 x
2019-12-31 ₩11958.34 ₩96200.00 x
2020-12-31 ₩12149.68 ₩96200.00 x
2021-12-31 ₩13319.26 ₩96200.00 x
2022-12-31 ₩13731.66 ₩96200.00 x
2023-12-31 ₩15873.90 ₩96200.00 x
2024-12-31 ₩20450.44 ₩96200.00 x
2025-12-31 ₩23663.23 ₩96200.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Cosmecca Korea Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 17.98%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 7.09%
  • • Asset Turnover: 1.01x
  • • Equity Multiplier: 2.50x
  • Recent ROE (17.98%) is above the historical average (9.15%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 10.97% 6.97% 1.15x 1.36x ₩1.02 Billion
2017 8.75% 5.45% 1.21x 1.33x ₩-1.41 Billion
2018 7.18% 2.96% 0.96x 2.52x ₩-3.53 Billion
2019 3.81% 1.40% 0.99x 2.75x ₩-7.91 Billion
2020 2.02% 0.77% 0.94x 2.77x ₩-10.35 Billion
2021 6.26% 2.25% 1.01x 2.75x ₩-5.32 Billion
2022 1.81% 0.67% 1.02x 2.68x ₩-12.01 Billion
2023 13.17% 4.74% 1.09x 2.55x ₩5.37 Billion
2024 19.60% 8.16% 1.01x 2.37x ₩20.96 Billion
2025 17.98% 7.09% 1.01x 2.50x ₩20.17 Billion

Industry Comparison

This section compares Cosmecca Korea Co. Ltd's net assets metrics with peer companies in the Household & Personal Products industry.

Industry Context

  • Industry: Household & Personal Products
  • Average net assets among peers: $953,443,429,694
  • Average return on equity (ROE) among peers: -12.20%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Cosmecca Korea Co. Ltd (241710) ₩334.61 Billion 10.97% 1.20x $696.27 Million
Amore Group (002790) $2.37 Trillion 3.37% 0.26x $1.39 Billion
Amorepacific Group (002795) $6.24 Trillion 2.28% 0.18x $96.97 Million
Hankook Cosmetics Manufacturing Co Ltd (003350) $44.01 Billion 21.85% 0.51x $145.31 Million
Daelim Trading (006570) $141.66 Billion 0.00% 1.45x $18.66 Million
Monalisa (012690) $68.62 Billion 7.93% 0.17x $32.80 Million
Medience Co. LTD (014100) $47.18 Billion 12.69% 1.10x $12.10 Million
Leaders Cosmetics Co. Ltd (016100) $28.92 Billion -191.50% 3.60x $13.62 Million
Aekyung Industrial Co Ltd (018250) $400.61 Billion 10.62% 0.25x $177.04 Million
Kolmar Holding (024720) $184.21 Billion 10.73% 0.45x $193.14 Million
Jayjun Co Ltd (025620) $9.08 Billion 0.00% 5.14x $62.14 Million

About Cosmecca Korea Co. Ltd

KQ:241710 Korea Household & Personal Products
Market Cap
$696.27 Million
₩1.03 Trillion KRW
Market Cap Rank
#10224 Global
#263 in Korea
Share Price
₩96200.00
Change (1 day)
-0.72%
52-Week Range
₩63900.00 - ₩153900.00
All Time High
₩153900.00
About

Cosmecca Korea Co., Ltd. engages in the research and development, manufacture, and sale of skincare products in South Korea and internationally. It offers skincare products, including lotion/toner, cream, essence, cleansers, Korean herbal products, mask sheet, scalp care, home scents, body and bath, exfoliators, and treatment products, as well as products for men, babies, and children; functional… Read more